Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002488469 | SCV002776021 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001700860 | SCV003820282 | uncertain significance | not provided | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230690 | SCV003928668 | uncertain significance | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700860 | SCV001921281 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700860 | SCV001974445 | uncertain significance | not provided | no assertion criteria provided | clinical testing |